Infant, Extremely Premature

• 

  Subject Areas on Research

  • Admission Temperature and Associated Mortality and Morbidity among Moderately and Extremely Preterm Infants. 
  • An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants. 
  • Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants. 
  • Behavioral Problems and Socioemotional Competence at 18 to 22 Months of Extremely Premature Children. 
  • Between-hospital variation in treatment and outcomes in extremely preterm infants. 
  • Causes and timing of death in extremely premature infants from 2000 through 2011. 
  • Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus. 
  • Congenital Heart Disease in Premature Infants 25-32 Weeks' Gestational Age. 
  • Delay in retinal photoreceptor development in very preterm compared to term infants. 
  • Development and validation of the Proxy-Reported Pulmonary Outcomes Scale for premature infants. 
  • Developmental outcomes of extremely preterm infants born to adolescent mothers. 
  • Differences in Eccentricity Index and Systolic-Diastolic Ratio in Extremely Low-Birth-Weight Infants with Bronchopulmonary Dysplasia at Risk of Pulmonary Hypertension. 
  • Diuretic exposure in premature infants from 1997 to 2011. 
  • Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial. 
  • Factors associated with feeding progression in extremely preterm infants. 
  • Genome-wide association study of sepsis in extremely premature infants. 
  • Identification of Extremely Premature Infants at Low Risk for Early-Onset Sepsis. 
  • Improved survival and neurodevelopmental outcomes among extremely premature infants born near the limit of viability. 
  • Improving the Process of Enteral Nutrition Preparation With Milk Technicians: Perceptions of Cost, Time, and Quality. 
  • In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia. 
  • Integrating neurocritical care approaches into neonatology: should all infants be treated equitably? 
  • Late-onset Sepsis in Extremely Premature Infants: 2000-2011. 
  • Markers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed Extubation. 
  • Optimizing protein intake in premature infants: a neonatal quality improvement project. 
  • Outcome of extremely preterm infants (<1,000 g) with congenital heart defects from the National Institute of Child Health and Human Development Neonatal Research Network. 
  • PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi. 
  • PaCO2 in surfactant, positive pressure, and oxygenation randomised trial (SUPPORT). 
  • Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort. 
  • Rifampin use and safety in hospitalized infants. 
  • Should Neonatologists Give Opinions Withdrawing Life-sustaining Treatment? 
  • Survival and Neurodevelopmental Outcomes among Periviable Infants. 
  • Thinner Retinal Nerve Fiber Layer in Very Preterm Versus Term Infants and Relationship to Brain Anatomy and Neurodevelopment. 
  • Timing for the Introduction of Cycled Light for Extremely Preterm Infants: A Randomized Controlled Trial. 
  • Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. 
  • Use of antihypotensive therapies in extremely preterm infants. 
  • Use of prophylactic antibiotics in women with previable prelabor rupture of membranes. 
  • Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis.